Factors related to menopausal symptom management decisions

被引:16
作者
Carpenter, Janet S. [1 ]
Byrne, Margaret M. [2 ]
Studts, Jamie L. [3 ]
机构
[1] Indiana Univ, Dept Adult Hlth, Sch Nursing, Indianapolis, IN 46202 USA
[2] Univ Miami, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA
[3] Univ Kentucky, Dept Behav Sci, Coll Med, Lexington, KY 40536 USA
关键词
Menopause; Decision; Decision making; Symptom management; ESTROGEN PLUS PROGESTIN; HORMONE-REPLACEMENT THERAPY; INITIATIVE RANDOMIZED-TRIAL; BREAST-CANCER; WOMEN; RISK; NEEDS;
D O I
10.1016/j.maturitas.2011.06.002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To systematically review the literature regarding factors related to women's menopausal symptom management decision making. Methods: The PubMed.gov online search engine was queried using pre-selected inclusion and exclusion criteria. Reference lists of articles were also reviewed to identify potentially missed articles. Full-text, English-language, peer-reviewed articles on factors related to menopausal symptom management decisions were reviewed. Results: A total of 16 articles (15 data-based, 1 review of literature) from 6 different countries were reviewed. Most articles were related to decisions about one class of therapies and did not take into account all available therapeutic options. In the 15 data-based articles, diverse methods were used: qualitative (47%), quantitative (47%), and mixed (6%), with most being cross-sectional (93%). Very few of the data-based articles were based on a conceptual model (20%) and none used findings to derive an explanatory or predictive model. Most samples were not representative of special populations, such as women with breast cancer. Factors fell into four broad categories: (1) individual characteristics (demographics, menopause experience. symptomatology); (2) values, attitudes, beliefs, and preferences (attitudes and beliefs about menopause and treatments, preferred modalities, tolerance for risks/side effects); (3) facts and information about menopause and symptom management (amount, type, source, credibility, availability); and (4) health care context (health care provider communication, trust, availability/time, knowledge, relationship). Conclusions: Additional descriptive studies are needed understand women's menopausal symptom management decisions in the context of all available therapies so that a comprehensive model of menopausal symptom management decision making can be specified. Additional understanding is needed regarding decisions in special populations of menopausal women such as breast cancer survivors, a group for whom menopausal symptom management can be particularly complex. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:10 / 15
页数:6
相关论文
共 23 条
  • [1] Alfred Ann, 2006, Aust Fam Physician, V35, P270
  • [2] Negotiating Competing Discourses: The Decision to Take Menopausal Hormone Therapy Following Surgical Menopause
    Burrell, Beverley
    Valledor, Vivienne
    Crowe, Marie
    Whitehead, Lisa
    [J]. WOMEN & HEALTH, 2010, 50 (06) : 527 - 543
  • [3] A systematic review of menopausal symptom management decision aid trials
    Carpenter, Janet S.
    Studts, Jamie L.
    Byrne, Margaret M.
    [J]. MATURITAS, 2011, 69 (01) : 11 - 21
  • [4] Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial
    Cauley, JA
    Robbins, J
    Chen, Z
    Cummings, SR
    Jackson, RD
    LaCroix, AZ
    LeBoff, M
    Lewis, CE
    McGowan, J
    Neuner, J
    Pettinger, M
    Stefanick, ML
    Wactawski-Wende, J
    Watts, NB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13): : 1729 - 1738
  • [5] Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial
    Chlebowski, RT
    Hendrix, SL
    Langer, RD
    Stefanick, ML
    Gass, M
    Lane, D
    Rodabough, RJ
    Gilligan, MA
    Cyr, MG
    Thomson, CA
    Khandekar, J
    Petrovitch, H
    McTiernan, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (24): : 3243 - 3253
  • [6] Estrogen plus progestin and risk of venous thrombosis
    Cushman, M
    Kuller, LH
    Prentice, R
    Rodabough, RJ
    Psaty, BM
    Stafford, RS
    Sidney, S
    Rosendaal, FR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (13): : 1573 - 1580
  • [7] Hormone therapy after the Women's Health Initiative: A qualitative study
    French L.M.
    Smith M.A.
    Holtrop J.S.
    Holmes-Rovner M.
    [J]. BMC Family Practice, 7 (1)
  • [8] Changing use of hormone therapy among minority women since the Women's Health Initiative
    Helenius, Ira M.
    Korenstein, Deborah
    Halm, Ethan A.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (02): : 216 - 222
  • [9] Decision-making about the use of hormone therapy among perimenopausal women
    Huston, Sally A.
    Bagozzi, Richard P.
    Kirking, Duane M.
    [J]. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 2010, 15 : 231 - 251
  • [10] Women's decision making about the use of natural health products at menopause: A needs assessment and patient decision aid
    Legare, France
    Stacey, Dawn
    Dodin, Sylvie
    O'Connor, Annette
    Richer, Monique
    Griffiths, Frances
    Leblanc, Annie
    Rousseau, Jean L. C.
    Tapp, Sylvie
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2007, 13 (07) : 741 - 749